What Should Men On TRT Monitor At Age 61?

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Already a member? Sign In

Timeline

00:00

A 61-year-old man on testosterone asks about fatigue, estradiol, ferritin, and his TRT regimen, and Dr. O’Connor recommends finding the lowest effective testosterone dose while closely monitoring the ABCDs™, cardiovascular risk, and age-appropriate screening.

01:35

Dr. O’Connor focuses on ferritin and androgen-induced erythrocytosis, explaining that iron stores should not be depleted while unusually high ferritin levels should be rechecked and investigated.

Video Summary

A 61-year-old man on testosterone asks how to manage fatigue, estradiol, ferritin, and long-term health. Dr. O’Connor recommends finding the lowest effective testosterone dose and using a more consistent dosing schedule rather than giving large injections every two weeks.

The discussion quickly expands to the ABCDs™ framework because age and long-term testosterone use make broader health monitoring increasingly important. Dr. O’Connor emphasizes A1C, blood pressure, coronary artery calcium and plaque assessment, PSA, skin screening, colorectal cancer screening, and continued evaluation of cardiovascular risk.

Blood health is also reviewed through hemoglobin, hematocrit, ferritin, sleep apnea, and androgen-induced erythrocytosis. Dr. O’Connor cautions against allowing ferritin to become depleted while also noting that unusually high ferritin, such as levels above 300, deserves repeat testing and further evaluation.

Drug Callouts

Testosterone

The member is using testosterone at age 61, and Dr. O’Connor recommends finding the lowest effective dose and avoiding widely spaced large injections. He favors a more consistent dosing approach while monitoring cardiovascular, metabolic, prostate, and blood-related health.

Condition Callouts

Androgen-Induced Erythrocytosis

Dr. O’Connor discusses testosterone-related increases in red blood cell production through hemoglobin and hematocrit monitoring. He emphasizes considering ferritin and sleep apnea alongside the CBC so men on testosterone do not manage erythrocytosis while overlooking iron depletion or other contributing factors.

Sleep Apnea

Sleep apnea is mentioned as an important contributor to elevated red blood cell production in men using testosterone. Dr. O’Connor includes it when discussing ways to understand and control androgen-induced erythrocytosis rather than focusing on testosterone alone.

Prediabetes

Dr. O’Connor emphasizes checking A1C in a 61-year-old man on testosterone because worsening glucose control and prediabetes are important long-term metabolic risks within the ABCDs™ framework.

Coronary Artery Disease

Dr. O’Connor recommends evaluating coronary risk through calcium scoring and determining whether arterial plaque is present. For an older man remaining on testosterone, cardiovascular screening becomes an important part of long-term health monitoring.

Key Takeaways

Dr. O’Connor recommends using the lowest effective testosterone dose and avoiding unnecessarily large, widely spaced injections.
Men over 60 on TRT should monitor A1C, blood pressure, cardiovascular risk, PSA, and age-appropriate cancer screening.
Coronary artery calcium scoring can help assess whether arterial plaque is already present in an older man using testosterone.
Hemoglobin and hematocrit should be interpreted together with ferritin and other factors that influence androgen-induced erythrocytosis.
Ferritin should not be allowed to become depleted, while unusually high levels such as those above 300 warrant repeat testing and further evaluation.